Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/29433804/ below:

Stereotactic Breast Biopsy With Benign Results Does Not Negatively Affect Future Screening Adherence

Affiliations

• ¹ Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, New York, New York. Electronic address: Alana.Amarosa@nyumc.org.
• ² Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, New York, New York.

• PMID: 29433804
• DOI: 10.1016/j.jacr.2017.12.034

Item in Clipboard

Alana A Lewin et al. J Am Coll Radiol. 2018 Apr.

• ¹ Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, New York, New York. Electronic address: Alana.Amarosa@nyumc.org.
• ² Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, New York, New York.

• PMID: 29433804
• DOI: 10.1016/j.jacr.2017.12.034

Item in Clipboard

Purpose: To evaluate whether false-positive stereotactic vacuum-assisted breast biopsy (SVAB) affects subsequent mammographic screening adherence.

Materials and methods: This Institutional Review Board-approved, HIPAA-compliant retrospective review of women with SVAB was performed between 2012 and 2014. Patient age, clinical history, biopsy pathology, and first postbiopsy screening mammogram were reviewed. Statistical analyses were performed using Fisher's exact, Mann-Whitney, and χ² tests.

Results: There were 913 SVABs performed in 2012 to 2014 for imaging detected lesions; of these, malignant or high-risk lesions or biopsies resulting in a recommendation of surgical excision were excluded, leaving 395 SVABs yielding benign pathology in 395 women. Findings were matched with a control population consisting of 45,126 women who had a BI-RADS 1 or 2 screening mammogram and did not undergo breast biopsy. In all, 191 of 395 (48.4%) women with a biopsy with benign results and 22,668 of 45,126 (50.2%) women without biopsy returned for annual follow-up >9 months and ≤18 months after the index examination (P = .479). In addition, 57 of 395 (14.4%) women with a biopsy with benign results and 3,336 of 45,126 (7.4%) women without biopsy returned for annual follow-up >18 months after the index examination (P < .001). Older women, women with personal history of breast cancer, and women with postbiopsy complication after benign SVAB were more likely to return for screening (P = .026, P = .028, and P = .026, respectively).

Conclusion: The findings in our study suggest that SVABs with benign results do not negatively impact screening mammography adherence. The previously described "harms" of false-positive mammography and biopsy may be exaggerated.

Keywords: Stereotactic biopsy; adherence; benign breast biopsy; screening.

Copyright © 2018 American College of Radiology. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

• What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence.

  Gao Y, Albert M, Young Lin LL, Lewin AA, Babb JS, Heller SL, Moy L. Gao Y, et al. Radiology. 2018 May;287(2):423-431. doi: 10.1148/radiol.2017171665. Epub 2018 Jan 29. Radiology. 2018. PMID: 29378151

• Frequency of Discordant Lesions and False-negative Cancers at Stereotactic Vacuum-assisted Biopsy.

  Heller SL, Jaglan S, Babb JS, Melsaether A, Toth HB, Moy L. Heller SL, et al. Acad Radiol. 2016 Aug;23(8):994-9. doi: 10.1016/j.acra.2016.03.023. Epub 2016 May 5. Acad Radiol. 2016. PMID: 27161209

• Overstated Harms of Breast Cancer Screening? A Large Outcomes Analysis of Complications Associated With 9-Gauge Stereotactic Vacuum-Assisted Breast Biopsy.

  Lin LLY, Gao Y, Lewin AA, Toth HK, Heller SL, Moy L. Lin LLY, et al. AJR Am J Roentgenol. 2019 Apr;212(4):925-932. doi: 10.2214/AJR.18.20421. Epub 2019 Feb 11. AJR Am J Roentgenol. 2019. PMID: 30741561

• False-negative diagnoses at stereotactic vacuum-assisted needle breast biopsy: long-term follow-up of 1,280 lesions and review of the literature.

  Jackman RJ, Marzoni FA Jr, Rosenberg J. Jackman RJ, et al. AJR Am J Roentgenol. 2009 Feb;192(2):341-51. doi: 10.2214/AJR.08.1127. AJR Am J Roentgenol. 2009. PMID: 19155393 Review.

• Benefits and Harms of Breast Cancer Screening: A Systematic Review.

  Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD. Myers ER, et al. JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. JAMA. 2015. PMID: 26501537 Review.

• Breast cancer screening.

  Gordon PB. Gordon PB. Can Fam Physician. 2019 Jul;65(7):457-459. Can Fam Physician. 2019. PMID: 31300424 Free PMC article. No abstract available.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3